This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.
In this episode of the Drug Solutions podcast, Felicity Thomas, Associate Editorial Director, chats with a host of experts about the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.
Erik Wiklund is CEO of Circio—a biotechnology company developing a novel circular RNA vector platform.
Preeya Beczek isdirector of Beczek Consulting, a specialistin regulatory affairs and compliance.
Edwin Stone is CEO of Cellular Origins—a company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies.
Miguel Forte is president of the International Society for Cell & Gene Therapy, board member of the Alliance for Regenerative Medicine, and CEO of Kiji Therapeutics
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.